Matches in Wikidata for { <http://www.wikidata.org/entity/Q63319028> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q63319028 description "assaig clínic" @default.
- Q63319028 description "clinical trial" @default.
- Q63319028 description "clinical trial" @default.
- Q63319028 description "clinical trial" @default.
- Q63319028 description "clinical trial" @default.
- Q63319028 description "ensaio clínico" @default.
- Q63319028 description "ensayo clínico" @default.
- Q63319028 description "ensayu clínicu" @default.
- Q63319028 description "essai clinique" @default.
- Q63319028 description "klinisch onderzoek" @default.
- Q63319028 description "клінічне випробування" @default.
- Q63319028 description "կլինիկական փորձարկում" @default.
- Q63319028 name "Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With Osteoarthritis" @default.
- Q63319028 type Item @default.
- Q63319028 label "Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With Osteoarthritis" @default.
- Q63319028 prefLabel "Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With Osteoarthritis" @default.
- Q63319028 P1050 Q63319028-6F6B0089-307E-444B-B7B2-2EA4BA86AADF @default.
- Q63319028 P1132 Q63319028-F6325BB9-9FA3-42AE-95DD-C6C7FEF64DA3 @default.
- Q63319028 P1476 Q63319028-F2CA5266-ECD4-4418-8835-318727FF6192 @default.
- Q63319028 P2899 Q63319028-54208460-ED1A-419E-8576-E38DE1D2F2BF @default.
- Q63319028 P3098 Q63319028-A7A0A5BE-F44F-41F0-B585-FC07C98F8D3F @default.
- Q63319028 P31 Q63319028-4493D83C-0EC0-4D30-B26B-BA2EEE796F41 @default.
- Q63319028 P4844 Q63319028-015A36F2-FAD7-4311-B4D3-76D3AAF3F067 @default.
- Q63319028 P4844 Q63319028-804F5155-07AB-4F12-88FB-31BB2E20E264 @default.
- Q63319028 P580 Q63319028-50F85F7A-F0A3-47EF-87B7-56B5E879C811 @default.
- Q63319028 P582 Q63319028-F2C55252-DA37-4987-8685-4105BBBD1EE6 @default.
- Q63319028 P6099 Q63319028-781C6AF6-EA10-4F40-82B4-F117821C24B0 @default.
- Q63319028 P8363 Q63319028-EDDB07FA-ACE1-466C-A7F1-860044F51AB0 @default.
- Q63319028 P859 Q63319028-180D6D47-18C0-4D18-BE7A-7156EB45C982 @default.
- Q63319028 P1050 Q62736 @default.
- Q63319028 P1132 "+239" @default.
- Q63319028 P1476 "A Phase III, 12-Week, Randomized, Active-Comparator-Controlled, Parallel-Group, Double Blind Study in Korea to Assess the Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Patients With Osteoarthritis" @default.
- Q63319028 P2899 "+40" @default.
- Q63319028 P3098 "NCT01554163" @default.
- Q63319028 P31 Q30612 @default.
- Q63319028 P4844 Q408801 @default.
- Q63319028 P4844 Q631202 @default.
- Q63319028 P580 "2012-03-01T00:00:00Z" @default.
- Q63319028 P582 "2013-03-01T00:00:00Z" @default.
- Q63319028 P6099 Q42824827 @default.
- Q63319028 P8363 Q78089383 @default.
- Q63319028 P859 Q58219685 @default.